Safety, Tolerability, and Efficacy of BVS857 in Patients With Spinal and Bulbar Muscular Atrophy
Clinical trial NCT02024932 · COMPLETED
Trial details
- NCT number
- NCT02024932
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-04
- Primary completion
- 2016-04-13
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.